Acadia Healthcare (NASDAQ:ACHC) Cut to “Sell” at StockNews.com

Acadia Healthcare (NASDAQ:ACHC) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Monday.

A number of other analysts have also recently issued reports on the stock. Barclays cut their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Royal Bank of Canada dropped their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $73.38.

Acadia Healthcare Stock Up 1.2 %

ACHC traded up $0.53 on Monday, hitting $44.85. 3,484,631 shares of the company were exchanged, compared to its average volume of 2,339,944. The stock’s fifty day moving average is $40.70 and its 200-day moving average is $58.54. Acadia Healthcare has a 12 month low of $36.50 and a 12 month high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market cap of $4.17 billion, a PE ratio of 14.70, a PEG ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same period last year, the business earned $0.91 earnings per share. Equities research analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors have recently modified their holdings of the business. Point72 Asset Management L.P. grew its position in Acadia Healthcare by 266.0% in the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock valued at $153,339,000 after acquiring an additional 1,650,040 shares during the last quarter. Wellington Management Group LLP increased its position in Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares in the last quarter. Millennium Management LLC boosted its position in Acadia Healthcare by 3,067.8% in the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after buying an additional 1,055,894 shares in the last quarter. Holocene Advisors LP grew its stake in shares of Acadia Healthcare by 201.5% during the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock worth $61,667,000 after buying an additional 649,997 shares during the last quarter. Finally, William Blair Investment Management LLC increased its holdings in shares of Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after buying an additional 604,070 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.